Clinical Value of Inflammatory Cytokines in Patients with Aneurysmal Subarachnoid Hemorrhage

References

• Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655–666. doi:10.1016/s0140-6736(16)30668-7
   PubMed Web of Science ®Google Scholar
• Owen CM, Montemurro N, Lawton MT. Microsurgical management of residual and recurrent aneurysms after coiling and clipping: an experience with 97 patients. Neurosurgery. 2015;62(Suppl 1):92–102. doi:10.1227/neu.0000000000000791
   PubMedGoogle Scholar
• Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: state of the art and future perspectives. Surg Neurol Int. 2017;8:11. doi:10.4103/2152-7806.198738
   PubMedGoogle Scholar
• English SW. Long-term outcome and economic burden of aneurysmal subarachnoid hemorrhage: are we only seeing the tip of the iceberg?. Neurocrit Care. 2020;33(1):37–38. doi:10.1007/s12028-020-00943-1
   PubMed Web of Science ®Google Scholar
• Saand AR, Yu F, Chen J, Chou SH. Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?. J Cereb Blood Flow Metab. 2019;39(6):959–988. doi:10.1177/0271678X19841443
   PubMed Web of Science ®Google Scholar
• Muroi C, Hugelshofer M, Seule M, et al. Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013;72(3):367–375. doi:10.1227/NEU.0b013e31828048ce
   PubMed Web of Science ®Google Scholar
• Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70(4):534–537. doi:10.1136/jnnp.70.4.534
   PubMed Web of Science ®Google Scholar
• Zhong W, Zhang Z, Zhao P, et al. The impact of initial systemic inflammatory response after aneurysmal subarachnoid hemorrhage. Turk Neurosurg. 2017;27(3):346–352. doi:10.5137/1019-5149.Jtn.16193-15.1
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–2395. doi:10.1161/strokeaha.110.589275
   PubMed Web of Science ®Google Scholar
• Drake CG. Report of world federation of neurological surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68(6):985–986. doi:10.3171/jns.1988.68.6.0985
   PubMed Web of Science ®Google Scholar
• Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the fisher scale revisited. Stroke. 2001;32(9):2012–2020. doi:10.1161/hs0901.095677
   PubMed Web of Science ®Google Scholar
• Broderick JP, Adeoye O, Elm J. Evolution of the modified rankin scale and its use in future stroke trials. Stroke. 2017;48(7):2007–2012. doi:10.1161/strokeaha.117.017866
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25–44. doi:10.1016/j.pneurobio.2013.11.003
   PubMed Web of Science ®Google Scholar
• Osuka K, Watanabe Y, Suzuki C, Iwami K, Miyachi S. Sequential expression of neutrophil chemoattractants in cerebrospinal fluid after subarachnoid hemorrhage. J Neuroimmunol. 2021;357:577610. doi:10.1016/j.jneuroim.2021.577610
   PubMed Web of Science ®Google Scholar
• Wu F, Liu Z, Li G, et al. Inflammation and oxidative stress: potential targets for improving prognosis after subarachnoid hemorrhage. Front Cell Neurosci. 2021;15:739506. doi:10.3389/fncel.2021.739506
   PubMed Web of Science ®Google Scholar
• Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 2012;97(1):14–37. doi:10.1016/j.pneurobio.2012.02.003
   PubMed Web of Science ®Google Scholar
• Gris T, Laplante P, Thebault P, et al. Innate immunity activation in the early brain injury period following subarachnoid hemorrhage. J Neuroinflammation. 2019;16(1):253. doi:10.1186/s12974-019-1629-7
   PubMed Web of Science ®Google Scholar
• Schiller M, Ben-Shaanan TL, Rolls A. Neuronal regulation of immunity: why, how and where?. Nat Rev Immunol. 2021;21(1):20–36. doi:10.1038/s41577-020-0387-1
   PubMed Web of Science ®Google Scholar
• Giede-Jeppe A, Reichl J, Sprügel MI, et al. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019;132(2):400–407. doi:10.3171/2018.9.Jns181975
   PubMed Web of Science ®Google Scholar
• Li R, Yuan Q, Su Y, Chopp M, Yan T, Chen J. Immune response mediates the cardiac damage after subarachnoid hemorrhage. Exp Neurol. 2020;323:113093. doi:10.1016/j.expneurol.2019.113093
   PubMed Web of Science ®Google Scholar
• Beseoglu K, Steiger HJ. Elevated glycated hemoglobin level and hyperglycemia after aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2017;163:128–132. doi:10.1016/j.clineuro.2017.10.037
   PubMed Web of Science ®Google Scholar
• Hanhai Z, Bin Q, Shengjun Z, et al. Neutrophil extracellular traps, released from neutrophil, promote microglia inflammation and contribute to poor outcome in subarachnoid hemorrhage. Aging. 2021;13(9):13108–13123. doi:10.18632/aging.202993
   PubMedGoogle Scholar
• Al-Mufti F, Amuluru K, Damodara N, et al. Admission neutrophil-lymphocyte ratio predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 2019;11(11):1135–1140. doi:10.1136/neurintsurg-2019-014759
   PubMed Web of Science ®Google Scholar
• Kuo LT, Huang AP. The pathogenesis of hydrocephalus following aneurysmal subarachnoid hemorrhage. Int J Mol Sci. 2021;22(9). doi:10.3390/ijms22095050
   Web of Science ®Google Scholar
• Rass V, Helbok R. Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2019;19(10):78. doi:10.1007/s11910-019-0990-3
   PubMed Web of Science ®Google Scholar
• Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58. doi:10.1038/nrneurol.2013.246
   PubMed Web of Science ®Google Scholar
• Sholl-Franco A, da Silva AG, Adão-Novaes J. Interleukin-4 as a neuromodulatory cytokine: roles and signaling in the nervous system. Ann NY Acad Sci. 2009;1153:65–75. doi:10.1111/j.1749-6632.2008.03962.x
   PubMed Web of Science ®Google Scholar
• Sheikh AM, Nagai A, Wakabayashi K, et al. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5. Neurobiol Dis. 2011;41(3):717–724. doi:10.1016/j.nbd.2010.12.009
   PubMed Web of Science ®Google Scholar
• Chaudhry SR, Kahlert UD, Kinfe TM, et al. Elevated systemic il-10 levels indicate immunodepression leading to nosocomial infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in patients. Int J Mol Sci. 2020;21(5):1569. doi:10.3390/ijms21051569
   PubMed Web of Science ®Google Scholar
• Garcia JM, Stillings SA, Leclerc JL, et al. Role of interleukin-10 in acute brain injuries. Front Neurol. 2017;8:244. doi:10.3389/fneur.2017.00244
   PubMed Web of Science ®Google Scholar
• Savarraj J, Parsha K, Hergenroeder G, et al. Early brain injury associated with systemic inflammation after subarachnoid hemorrhage. Neurocrit Care. 2018;28(2):203–211. doi:10.1007/s12028-017-0471-y
   PubMed Web of Science ®Google Scholar
• Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625–637. doi:10.1007/s00401-015-1402-7
   PubMed Web of Science ®Google Scholar
• Chaudhry SR, Güresir E, Vatter H, et al. Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23/IL-17 inflammatory axis. Cytokine. 2017;97:96–103. doi:10.1016/j.cyto.2017.05.025
   PubMed Web of Science ®Google Scholar
• Ullrich KA, Schulze LL, Paap EM, Müller TM, Neurath MF, Zundler S. Immunology of IL-12: an update on functional activities and implications for disease. EXCLI J. 2020;19:1563–1589. doi:10.17179/excli2020-3104
   PubMed Web of Science ®Google Scholar
• Savarraj JPJ, Parsha K, Hergenroeder GW, et al. Systematic model of peripheral inflammation after subarachnoid hemorrhage. Neurology. 2017;88(16):1535–1545. doi:10.1212/wnl.0000000000003842
   PubMed Web of Science ®Google Scholar
• Dong G, Li C, Hu Q, et al. Low-dose il-2 treatment affords protection against subarachnoid hemorrhage injury by expanding peripheral regulatory t cells. ACS Chem Neurosci. 2021;12(3):430–440. doi:10.1021/acschemneuro.0c00611
   PubMed Web of Science ®Google Scholar
• Wu K, Ma J, Bai W, et al. Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model. Sci Rep. 2016;6:31562. doi:10.1038/srep31562
   PubMed Web of Science ®Google Scholar
• Dutcher JP, Schwartzentruber DJ, Kaufman HL, et al. High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014. J Immunother Cancer. 2014;2(1):26. doi:10.1186/s40425-014-0026-0
   PubMedGoogle Scholar
• Roselli F, Chandrasekar A, Morganti-Kossmann MC. Interferons in traumatic brain and spinal cord injury: current evidence for translational application. Front Neurol. 2018;3:458. doi:10.3389/fneur.2018.00458
   Web of Science ®Google Scholar
• Cai L, Zeng H, Tan X, Wu X, Qian C, Chen G. The role of the blood neutrophil-to-lymphocyte ratio in aneurysmal subarachnoid hemorrhage. Front Neurol. 2021;12:671098. doi:10.3389/fneur.2021.671098
   PubMed Web of Science ®Google Scholar
• Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous system. Science. 2016;353(6301):766–771. doi:10.1126/science.aag2638
   PubMed Web of Science ®Google Scholar
• Galea J, Ogungbenro K, Hulme S, et al. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the subcutaneous interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg. 2018;128(2):515–523. doi:10.3171/2016.9.Jns16615
   PubMed Web of Science ®Google Scholar